Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2000 December;52(4) > Minerva Urologica e Nefrologica 2000 December;52(4):219-22

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

TECHNOLOGY NEWS   

Minerva Urologica e Nefrologica 2000 December;52(4):219-22

Copyright © 2000 EDIZIONI MINERVA MEDICA

language: English

From the intestinal neobladder to the bioartificial bladder: remarks on some biological implications

Alberti C.

University of Parma (Italy) L.D. of Surgical Semeiotics


PDF


In an attempt to avoid the complications associated with use of bowel for bladder augmentation or replacement (systemic metabolic imbalances, malignancy, etc.), various solutions have been proposed for an artificial orthotopic neobladder: total alloplastic prosthetic bladder in nonbiological material (silicon rubber, polyurethane, etc.); tissue-engineered bladder by the patient’s own urothelial – and smooth muscle – cells obtained by biopsy of a urinary segment with less neoplastic potential and cultured in vitro, then seeded onto biodegradable bladder-shaped scaffold, autografted in the original host; bladder augmentation or replacement using acellular matrix derived from small-intestinal submucosa or from bladder or ureter as a scaffold structure for the subsequent regrowth of functional organ. Tissue-engineering technology with autologous native cells is being undertaken for every type of organ within the urinary tract. At the present moment, other roads are less practicable, e.g. to obtain “spare bladders” from human therapeutic cloning or from transgenic-humanized animals.

top of page